Feng Lin
7 Papers
Feng Lin is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 5 publications.
Chat about Author
Papers
Anomaly Detection Framework for Wearables Data: A Perspective Review on Data Concepts, Data Analysis Algorithms and Prospects
Jithin S. Sunny,Chinari Pawan Kumar Patro,Khushi Karnani,Sandeep C. Pingle,Feng Lin,Misa Anekoji,Lawrence D. Jones,Santosh Kesari,Shashaanka Ashili +8 more
TL;DR: The nature of the wearables-associated data and the downstream processing methods for detecting anomalies are reviewed, and supervised and un-supervised techniques as well as semi-super supervised methods that overcome the challenges of missing andun-annotated healthcare data are reviewed.
MTAP loss: a possible therapeutic approach for glioblastoma
C. P. Patro,Nupur Biswas,Sandeep C. Pingle,Feng Lin,Misa Anekoji,Lawrence D. Jones,Santosh Kesari,Feng Wang,Shashaanka Ashili +8 more
TL;DR: In this article , the authors reviewed the effects of the loss of the 5′-methylthioadenosine phosphorylase (MTAP) gene for treating glioblastoma.
Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines
Feng Lin,Emma Z. Lin,Misa Anekoji,T. Ichim,Joyce Hu,Francesco M. Marincola,Lawrence D. Jones,Santosh Kesari,Shashaanka Ashili +8 more
TL;DR: An overview of mRNA vaccine delivery technologies, tumor antigen identification, combination therapies, and recent therapeutic outcomes, with a particular focus on brain cancer, underscores mRNA vaccines' potential in advancing personalized medicine for brain cancer.
7
Traumatic brain injury and immunological outcomes: the double-edged killer
TL;DR: In this article , the authors provide a better understanding of TBI's immunobiology and management protocols from an immunopathological perspective, and further elaborates on the risk factors, disease outcomes, and preclinical studies to design precisely targeted interventions for enhancing TBI outcomes.
4
Exploring the role of cerebrospinal fluid as analyte in neurologic disorders
Sandeep C. Pingle,Feng Lin,Misa Anekoji,C. P. Patro,Souvik Datta,Lawrence D. Jones,Santosh Kesari,Shashaanka Ashili +7 more
TL;DR: The use of CSF biomarkers for the diagnosis and treatment monitoring of different neurological diseases, including neurodegenerative diseases such as Alzheimer's disease, Parkinson disease, amyotrophic lateral sclerosis, and primary and secondary brain malignancies, is discussed in this article .
4